Phio Pharmaceuticals Corp.
PHIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,382 | $8,490 | $11,781 | $24,057 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $354 | $832 | $665 | $670 |
| Total Curr. Assets | $5,736 | $9,322 | $12,446 | $24,727 |
| Property Plant & Equip (Net) | $2 | $39 | $344 | $416 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $3 | $24 | $27 |
| Total NC Assets | $2 | $42 | $368 | $443 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,738 | $9,364 | $12,814 | $25,170 |
| Liabilities | – | – | – | – |
| Payables | $253 | $657 | $779 | $283 |
| Short-Term Debt | $0 | $35 | $135 | $125 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $762 | $942 | $1,025 | $2,660 |
| Total Curr. Liab. | $1,015 | $1,634 | $1,939 | $3,068 |
| LT Debt | $0 | $0 | $35 | $170 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $35 | $170 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $35 | $170 | $295 |
| Total Liabilities | $1,015 | $1,634 | $1,974 | $3,238 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $2 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$146,356 | -$139,206 | -$128,380 | -$116,900 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $151,079 | $146,936 | $139,218 | $138,832 |
| Total Equity | $4,723 | $7,730 | $10,840 | $21,932 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5,738 | $9,364 | $12,814 | $25,170 |
| Net Debt | -$5,382 | -$8,455 | -$11,611 | -$23,762 |